Menu
Exonate
Exonate develops and licenses Vascular Endothelial Growth Factors (VEGF) control agents that may be used as therapeutics in areas such as pain control, macular degeneration and cancer.
Drug discovery – wet AMD and cancer
School of Medicine
Profile
Exonate’s research in this area has identified therapeutic candidates for wet Age Related Macular Degeneration that can be administered as a simple eye drop, thereby over-coming the unpleasant need for monthly injections in the eye.
Competing injectable anti-VEGFdirected therapy currently constitutes the gold-standard treatment for wet Age Related Macular Degeneration (wAMD) and other neovascular diseases of the eye.
News and press releases
@ExonateUK on Twitter
Membership Matters -- October 2021 - It's World Sight Day week and we can't wait to show you what we have in store, plus our new ten-year sectoral strategy and more in this newsletter... https://mailchi.mp/iapb/membership-matters-oct2021-2626596
This is BIG! 🎉
We are over halfway to our goal of 1️⃣ million pledges by #WorldSightDay!
Have you pledged to #LoveYourEyes? Join the 576,621 who have! ☞ http://bit.ly/WSDPledge ❤️
#News for #Investors and #Media, Today, we welcome @CureVacRNA’s decision to focus on the promising second-generation #mRNA constructs we are developing together.
Geographic Access Disparities of Clinical Trials in Neovascular Age-Related Macular Degeneration in the United States By Rebecca Soares, MD. Nearly 75% of rural residents had to travel >60 miles to a clinical trial site. Higher travel burden: lower edu, more rural. #asrs2021
Full house for this mornings Wet AMD Symposium 1 and a jam packed day of presentations on the latest advancements in retina is on deck. What talks are you looking forward to? #ASRS2021
We’re excited to present the latest data from our innovative Ophthalmology pipeline at #ASRS2021. Learn more about our work to improve care for people with #VisionLoss: http://bit.ly/3lyfOK3
#RocheInnovation
AstraZeneca aims to lead a revolution in oncology to redefine cancer care in the UK through our commitment to science, patients and our people. If you want to join us on this mission, as a collaborator or colleague, please get in touch.
BREAKING NEWS:
The 2021 #NobelPrize in Physiology or Medicine has been awarded jointly to David Julius and Ardem Patapoutian “for their discoveries of receptors for temperature and touch.”
